| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |